There is some evidence that mitochondrial genes may contribute to susceptibility to multiple sclerosis (MS), and a mitochondrial DNA-encoded peptide, the N-terminal portion of NADH-dehydrogenase subunit 1, acts as a transplantation antigen in mice. We have analysed the DNA sequence of the corresponding region of human mitochondrial DNA in 87 patients with MS, 10 with Leber's hereditary optic neuropathy in association with an MSlike illness, and 31 control subjects. This sequence appears to be highly conserved. Only three base pair changes were identified, each being found once only in one control and two patients, and these are likely to be harmless polymorphisms. There is thus no evidence that polymorphism in this region contributes to genetic susceptibility in MS.
Introduction
Susceptibility to multiple sclerosis (MS) is thought to involve an interplay between genetic predisposition and as yet unidentified environmental triggers. Genetic predisposition probably involves genes encoded in the class II region of the histocompatibility locus and the immunoglobulin heavy chain variable region locus, but these do not entirely account for the degree of heritability deduced from several population based studies [4] . Two observations favour the hypothesis that mitochondrial genes, which are maternally inherited, may contribute to susceptibility. First, even taking the female preponderance of MS into account, females with MS are more likely to have affected children than males [14] . Second, a significant number of women with Leber's optic atrophy and the associated mutations of mitochondrial DNA (mtDNA) at base pairs (bp) 11778 or 3460 develop an illness that is indistinguishable from MS [6] [7] [8] . The products of the genetic loci thus far implicated in MS are involved in the restriction of the immune response and it is therefore possible that mitochondrial genes which have a similar role may make independent or epistatic contributions to susceptibility. In rodents there is evidence that mitochondrially encoded peptides can act as transplantation antigens. In particular, the murine maternally transmitted factor (MTF), encoded by mtDNA, is presented by the neoclassical major histocompatibility (MHC) class I antigen H-2M3 [9, 16] . MTF is the N-terminal region of NADH dehydrogenase subunit 1 (ND1) and variation of amino acid residue 6 determines MTF antigenicity [9] .
We have analysed mtDNA from patients with MS to determine whether variation in the corresponding region of human ND1 contributes to genetic susceptibility in MS.
Patients and methods
We investigated 87 patients with clinically definite, laboratory supported MS [ 12] . These consisted of 29 index cases from a study of affected sib pairs in the United Kingdom [13] , 51 index cases from the United Kingdom MS twin study [1 l] , and index cases from seven families in which members of more than one generation developed MS and transmission was exclusively maternal. In addition, we studied 10 patients with the Leber's hereditary optic neuropathy (LHON) mtDNA mutation at bp 11778 who developed an MS-like illness [7, 8] , and 31 control subjects.
DNA was extracted from blood using standard techniques. The N-terminal region of ND1 was amplified using the polymerase chain reaction (PCR) with one primer spanning bp 3054-3073 (light strand) and a biotinylated primer bp 3558-3539 (heavy strand) [1] . PCR fragments were purified with Magicprep (Promega) and single-stranded template was obtained by immobilisation on streptavidin-coated magnetic beads (Dynal). Direct sequencing of the region of interest was performed using internal primer 3225-3244 (light strand), fluorescent labelled dye terminators, and an automated sequencer (Applied Biosystems). Sequences were compared with the published sequence of the initial 51 bp of ND1 [1] .
Results
Sequence data corresponding to the first 17 amino acids of ND1 were obtained from 128 subjects. A single base pair change was observed in 1 of 31 controls (Table 1) . In 97 patients with MS and LHON/MS, two base changes occurred, one in each of two index cases from the MS twin study (Table 1) . No base change occurred more than once and each was homoplasmic. 
Discussion
These results show that polymorphism in the N-terminal 51 bp of ND1 is rare, our data indicating a sequence divergence rate of 0.04/100 bp. Analysis of restriction maps of mtDNA has suggested a rate of 0.25/100 bp over the entire NADH dehydrogenase coding region in Caucasians [3] , whilst direct sequencing of the ND genes in 10 patients (6 with mitochondrial myopathy, 2 with myotonic dystrophy and 2 controls) showed a polymorphism rate of 0.25 +_ 0.10/100 bp [10] . Studies of amino acid residue substitutions [2] suggest that none of the three base changes identified in this study produces amino acid changes which would significantly affect protein structure, either locally or in its overall folding pattern. They are highly likely to be harmless polymorphisms. The precise length of the MTF has yet to be determined. The minimal length of synthetic N-terminal ND 1 peptides that is recognised by MTF-restricted cytotoxic T lymphocytes is between 8 and 12 amino acids [15] . We identified no sequence changes affecting the sixth amino acid residue that determines MTF antigenicity in mice and, further, found no polymorphisms in any of the first nine amino acids. This suggests that the region of human mtDNA homologous to MTF in mice is particularly conserved.
We conclude that variation in the N-terminal region of ND1 is unlikely to contribute to susceptibility to MS. However, this clearly does not exclude the involvement of other mitochondrial genes. First, a unique feature of peptides bound and presented by H-2M3 is the requirement for N-formylation, and all mitochondrial, but not cytoplasmic, protein synthesis is initiated with N-formylmethionine [15] . Thus the N-terminal portions of other mtDNA-encoded proteins could be presented by a human equivalent of H-2M3, although such a molecule has not been positively identified. Second, there is evidence for a mtDNA-encoded antigen in the rat that is presented by classical class I MHC antigens. This antigen is not the same as MTF but has yet to be identified [5] . We suggest that further investigation of mitochondrial genetic susceptibility to MS is appropriate.
